US 12,403,326 B2
System for corneal cross-linking and correcting vision by using LED contact lens and eye dye
Sei Kwang Hahn, Seoul (KR); Sang Baie Shin, Gyeongsangbuk-do (KR); and Jong Hwan Mun, Seoul (KR)
Assigned to PHI BIOMED INC., Seoul (KR); and POSTECH ACADEMY-INDUSTRY FOUNDATION, Gyeongsangbuk-do (KR)
Appl. No. 17/642,565
Filed by PHI BIOMED INC., Seoul (KR); and POSTECH ACADEMY-INDUSTRY FOUNDATION, Gyeongsangbuk-do (KR)
PCT Filed Sep. 11, 2020, PCT No. PCT/KR2020/012280
§ 371(c)(1), (2) Date Mar. 11, 2022,
PCT Pub. No. WO2021/049898, PCT Pub. Date Mar. 18, 2021.
Claims priority of application No. 10-2019-0112695 (KR), filed on Sep. 11, 2019; and application No. 10-2020-0044528 (KR), filed on Apr. 13, 2020.
Prior Publication US 2022/0323780 A1, Oct. 13, 2022
Int. Cl. A61N 5/06 (2006.01); A61K 51/04 (2006.01); G02C 7/04 (2006.01)
CPC A61N 5/062 (2013.01) [A61K 51/0497 (2013.01); G02C 7/049 (2013.01); A61N 2005/0645 (2013.01); A61N 2005/0651 (2013.01); A61N 2005/0663 (2013.01)] 10 Claims
 
1. A system for injured cornea crosslinking, keratoconus treatment or vision correction, comprising:
a hyaluronic acid-dye conjugate; and
a contact lens including an LED light source.